...
首页> 外文期刊>Progress in Artificial Intelligence >Intrarenal Transplantation of Hypoxic Preconditioned Mesenchymal Stem Cells Improves Glomerulonephritis through Anti-Oxidation, Anti-ER Stress, Anti-Inflammation, Anti-Apoptosis, and Anti-Autophagy
【24h】

Intrarenal Transplantation of Hypoxic Preconditioned Mesenchymal Stem Cells Improves Glomerulonephritis through Anti-Oxidation, Anti-ER Stress, Anti-Inflammation, Anti-Apoptosis, and Anti-Autophagy

机译:缺氧预处理性间充质干细胞的内移植通过抗氧化,抗ER应激,抗炎,抗细胞凋亡和抗自噬改善肾小球肾炎

获取原文
获取原文并翻译 | 示例

摘要

To confer further therapeutic potential and prevent some adverse effects by the mesenchymal stem cells (MSCs) transplantation, we explored the effects of locally intrarenal arterial administration of hypoxic preconditioned MSCs in the anti-Thy1.1 induced rat glomerulonephritis. Proteinuria, histochemical staining, and western blotting were used to explore the therapeutic effects and mechanisms. Locally intrarenal arterial MSCs transplantation successfully implanted the fluorescent or CD44 labeled MSCs in the nephritic glomeruli, ameliorated proteinuria, and glomerulosclerosis in nephritic rats. Hypoxic preconditioning significantly upregulated hypoxic inducible factor-1 alpha/VEGF (HIF-1 alpha/VEGF) in the MSCs and was more efficient than normoxic MSCs in reducing the degree of urinary protein, glomerulosclerosis, fibrosis, macrophage/monocyte infiltration, GRP78 mediated endoplasmic reticulum stress, Beclin-1/LC3-II mediated autophagy, and Bax/Bcl-2/caspase 3 mediated apoptosis. Hypoxic MSCs could further promote intranuclear nuclear factor (erythroid-derived 2, Nrf2) and reduce nuclear factor kappa B expression in nephritic kidneys. As compared to normoxic MSCs, hypoxic MSCs transplantation significantly upregulated the renal expression of anti-oxidative response elements/enzymes including glutamate-cysteine ligase catalytic subunit, glutamate-cysteine ligase modifier subunit, glutathione peroxidase, catalase, Mn, and Cu/Zn superoxide dismutase. In summary, intrarenal hypoxic preconditioning MSCs transplantation was more effective to activate hypoxic inducible factor-1 alpha/VEGF/Nrf2 (HIF-1 alpha/VEGF/Nrf2) signaling, preserve anti-oxidant proteins and anti-oxidative responsive element proteins, and subsequently reduce glomerular apoptosis, autophagy, and inflammation.
机译:为了促进进一步的治疗潜力并防止间充质干细胞(MSCs)移植的一些不利影响,我们探讨了局部患有催眠预处理MSCs在抗THY1.1诱导的大鼠肾小球肾炎中的局部内动脉施用的影响。蛋白尿,组织化学染色和蛋白质印迹用于探索治疗效果和机制。局部内部动脉MSCs移植成功地植入了肾病大鼠肾炎肾小球,改善蛋白尿和肾小球粥样硬化的荧光或CD44标记的MSC。缺氧预处理显着上调MSC中的缺氧诱导因子-1α/ VEGF(HIF-1α/ VEGF),比常氧MSC更有效地降低尿蛋白程度,肾小球粥样硬化,纤维化,巨噬细胞/单核细胞浸润,GRP78介导的内质网状胁迫,BECLIN-1 / LC3-II介导的自噬,以及BAX / BCL-2 / CASPase 3介导的凋亡。缺氧MSCs可以进一步促进核心核因子(红细胞衍生的2,NRF2)并减少肾病肾脏中的核因子Kappa B表达。与常规MSCs相比,缺氧MSCs移植显着上调了抗氧化反应元素/酶的肾表达,包括谷氨酸半胱氨酸连接酶催化亚基,谷氨酸 - 半胱氨酸酶改性剂亚基,谷胱甘肽过氧化物酶,过氧化氢酶,Mn和Cu ​​/ Zn超氧化物歧化酶。总之,内缺氧预处理MSCs移植更有效地活化缺氧诱导因子-1α/ VEGF / NRF2(HIF-1α/ VEGF / NRF2)信号传导,保持抗氧化蛋白和抗氧化响应元素蛋白,随后减少肾小球凋亡,自噬和炎症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号